The Institute for Translational Medicine

联系PD/PI：Solway，Julian 第O章：总体 摘要 ITM 3.0：在整个芝加哥大都市推进卫生工作，实现卫生公平 芝加哥大学-拉什大学转化医学研究所（ITM）成立于2007年， 集合、整合和创造催化所需的智力、行政和物质资源 临床和转化科学的研究和研究培训。我们培训了大学科学家， 卫生保健提供者以及有关社区的利益相关者共同努力， 疾病的生物、行为和社会决定因素;开发和测试针对以下方面的干预措施： 这些机制;并以严格、高效、符合道德、尊重和 响应我们社区的优先事项和价值观。ITM利用了杰出的知识分子和 整个U芝加哥，拉什和ITM附属机构的物理资源-洛约拉大学芝加哥， 北岸大学健康系统，倡导奥罗拉医疗保健，和伊利诺伊理工学院-和 大量的多机构投资，以建立可持续的基础设施， 充满活力，自我完善的临床和转化研究之家。 现在，我们追求一个大胆的指导愿景“ITM 3.0”-扭转不利的健康后果， 结构性种族主义需要考虑和减轻社会，环境，行为， 心理因素（整个生活经验，我们称之为“社会组”）， 结构性种族主义损害健康。关注社会组是至关重要的，因为：1）社会组因素与 人类生物学加剧或导致疾病和伤害，以及2）任何来源的疾病都可能使 不良社会因素的负面影响。由于社会和生物系统，以及它们的 互动，确定健康，我们的CTSA中心必须为调查人员，学员和利益相关者提供 资源和知识，以说明和解决整个系统的健康干扰因素。我们 实现这一愿景的战略是建立新的培训机制、研究平台， 通信渠道，并采取措施防止伤害，以确保所有ITM调查人员和 各机构以符合道德的方式，从更广泛的社会组透镜来处理健康问题。然后我们 科学、机构和社区利益相关者可以共同设计、测试和传播生物技术， 在个人、社区和社会层面采取针对社会群体的干预措施， 共同定义的健康问题。ITM3.0将与整个芝加哥的合作伙伴携手合作， 国家，结合学术严谨与社区智慧，概念化，开发和部署 创新，公正和道德的干预措施/做法，以实现我们的共同目标，从而减少健康 结构性种族主义的影响 项目摘要/摘要第244页 联系PD/PI：Solway，Julian

Contact PD/PI: Solway, Julian Chapter O: Overall ABSTRACT ITM 3.0: ADVANCING HEALTH TOWARD HEALTH EQUITY THROUGHOUT METROPOLITAN CHICAGO The University of Chicago – Rush University Institute for Translational Medicine (ITM) was created in 2007 to assemble, integrate, and create the intellectual, administrative, and physical resources required to catalyze research and research training in Clinical and Translational Science. We have trained university scientists and health care providers as well as stakeholders from concerned communities to work together to determine the biological, behavioral, and social determinants of disease; to develop and test interventions directed toward those mechanisms; and to achieve these goals in a way that is rigorous, efficient, ethical, respectful of, and responsive to our communities’ priorities and values. The ITM has capitalized on outstanding intellectual and physical resources throughout UChicago, Rush, and ITM affiliate institutions – Loyola University Chicago, NorthShore University HealthSystem, Advocate Aurora Health Care, and Illinois Institute of Technology – and on substantial multi-institutional investments to build the sustainable infrastructure for a transformative, energetic, and self-improving home for clinical and translational research. Now, we pursue a bold guiding vision for “ITM 3.0” – that reversing the adverse health consequences of structural racism requires accounting for and mitigating the social, environmental, behavioral, and psychological factors (the entire lived experience, which we will call the “sociome”) through which structural racism impairs health. Focus on the sociome is critical because: 1) sociome factors interact with human biology to exacerbate or cause disease and injury, and 2) illness of any origin can compound the negative effects of adverse sociome factors. Since both sociome and biological systems, and their interactions, determine health, our CTSA hub must provide investigators, trainees, and stakeholders with the resources and knowledge to account for and address health disruptors throughout both systems. Our strategy to implement this vision is to create new training mechanisms, research platforms, communications channels, and safeguards against harm to ensure that all ITM investigators and institutions approach health problems with a wider-angle sociome lens in an ethical way. Then, our scientific, institutional, and community stakeholders can together design, test, and disseminate biological and/or sociome-directed interventions at the levels of individual, community, and society to improve mutually defined health concerns. ITM 3.0 will work hand-in-hand with partners throughout Chicagoland and the nation, combining academic rigor with community wisdom to conceptualize, develop and deploy innovative, just, and ethical interventions/practices to achieve our common goal, and so lessen the health impact of structural racism. Project Summary/Abstract Page 244 Contact PD/PI: Solway, Julian